curious if you could do a video on your thoughts or opinion on probiotics? Just read the article posted on Facebook, but would appreciate your own thoughts and studies you have read or are familiar with. Thanks in advance!
Honestly Charity I'm still learning about how gut flora impacts the immune system and the role of probiotics. I think there IS a role and that altering gut flora might help. I don't think we are at the point where we know WHICH exact combo of WHICH exact strains of bacteria are right. Anecdotally, I have heard plenty of PwMS tell me probiotics helps them GI symptoms quite a bit.
There is one therapy currently under investigation for possible remyelination called opicinumab. media.biogen.com/news-releases/news-release-details/biogen-announces-affinity-phase-2-trial-initiation-opicinumab
Why do you stop doing MRI’s after 60 years old when I had the worst ms attack ever at age 64.
Good video, but could be an excellent video if you could give us a reference range and if there is a cutoff for progression (e.g. 20% change)
Thank you
curious if you could do a video on your thoughts or opinion on probiotics? Just read the article posted on Facebook, but would appreciate your own thoughts and studies you have read or are familiar with. Thanks in advance!
Honestly Charity I'm still learning about how gut flora impacts the immune system and the role of probiotics. I think there IS a role and that altering gut flora might help. I don't think we are at the point where we know WHICH exact combo of WHICH exact strains of bacteria are right. Anecdotally, I have heard plenty of PwMS tell me probiotics helps them GI symptoms quite a bit.
Thank you for your feedback! Feel pretty damn lucky to have such a top notch neuro in my corner!
Hey Dr B,
I'd be interested to hear your thoughts on new therapies for Re-#Myelination in the pipeline please. TY VERY MUCH
There is one therapy currently under investigation for possible remyelination called opicinumab. media.biogen.com/news-releases/news-release-details/biogen-announces-affinity-phase-2-trial-initiation-opicinumab